Hostname: page-component-89b8bd64d-5bvrz Total loading time: 0 Render date: 2026-05-08T07:02:46.460Z Has data issue: false hasContentIssue false
  • English
  • Français

Translating Emergent Technologies into Novel Therapeutics: Tracing Complementarity and Co-evolution in the Cambridge–Boston Innovation Ecosystem – CORRIGENDUM

Published online by Cambridge University Press:  27 March 2026

Maki Umemura Open the ORCID record for Maki Umemura [Opens in a new window]
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.

Information

Type
Corrigendum
Information
Business History Review , Volume 99 , Issue 4 , Winter 2025 , pp. 705
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2026. Published by Cambridge University Press on behalf of The President and Fellows of Harvard College

The author regrets the inclusion of an error in the above article. The correction is listed as below:

  • Page 196 , bottom paragraph: Incorrectly attributes Alkermes to “Harvard Medical School.” The affiliation should be corrected to MIT.

References

Umemura, Maki. “Translating Emergent Technologies into Novel Therapeutics: Tracing Complementarity and Co-evolution in the Cambridge–Boston Innovation Ecosystem.” Business History Review 99, no. 2 (2025): 185–209. https://doi.org/10.1017/S000768052510086X CrossRefGoogle Scholar